Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia : The Effects of Atopy on AGA

Abstract EN

Background.

We examined the efficacy of a new regimen to treat AGA, with attention to male patients who are atopic.

Objective.

To assess the efficacy of a four-part regimen for the treatment of AGA in atopic and nonatopic patients.

NuH Hair is a novel topical combination of finasteride, dutasteride, and minoxidil, which is blended in a hypoallergenic lotion.

The other three components included Rogaine foam, Propecia, and ketoconazole shampoo.

Methods.

A prospective pilot study was conducted in 15 patients.

All patients were assessed for the presence of atopy.

Each patient served as their own control.

All patients were treated specifically with NuH Hair and were given the option to add any of the other components of the protocol to their regimen.

Photographs were taken of each patient's scalp at months 0, 1, 3, 6, and 9.

Results.

All 15 patients demonstrated significant growth of hair.

In those patients who utilized all 4 components, significant growth was achieved in as little as 30 days.

In those patients who choose only to utilize NuH Hair, significant growth was demonstrated after 3 months.

Conclusion.

Aggressively treating AGA achieves significant and rapid growth of new hair.

This is effective in atopic and nonatopic male patients.